Incidence and Predictors of Oral Steroid Use Shortly Following Lumbar Microdiscectomy

Henry Avetisian1, Will Karakash, David McCavitt

  • 1Department of Orthopaedic Surgery, Keck School of Medicine, The University of Southern California, Los Angeles, CA.

Spine
|March 24, 2025
PubMed
Abstract

Insights

Nearly 12% of patients undergoing lumbar microdiscectomy require oral steroids for postoperative radiculopathy. Female gender, opioid use, and fibromyalgia are key risk factors identified in this study.

Area of Science:

  • Neurosurgery
  • Orthopedic Surgery
  • Pain Management

Background:

  • Lumbar microdiscectomy (MD) frequently alleviates back and leg pain.
  • Some patients experience recurrent radicular pain post-MD, often managed with oral steroids.
  • The incidence and risk factors for steroid use post-MD are not well-defined.

Purpose of the Study:

  • Determine the incidence of oral glucocorticoid use within one month after lumbar microdiscectomy.
  • Identify patient- and procedure-related risk factors for this postoperative radiculopathy treatment.

Main Methods:

  • Retrospective cohort study utilizing the PearlDiver national database.
  • Analysis of 326,315 patients undergoing lumbar MD for disc herniation.
  • Stratification based on oral steroid prescription (postoperative days 1-30) and multivariate logistic regression.

Main Results:

  • 11.78% (38,455/326,315) of patients received oral steroids postoperatively.
  • Steroid recipients were more likely female and had higher Elixhauser Comorbidity Index (ECI).
  • Independent risk factors included opioid use, far lateral herniation, female gender, prior epidural steroid injection, fibromyalgia, tobacco use, delayed surgery, depression, higher ECI, and revision MD.

Conclusions:

  • A significant subset of lumbar microdiscectomy patients (11.78%) require oral steroids for postoperative radiculopathy.
  • Multiple patient and procedural factors are associated with increased steroid use.
  • Further research is needed to optimize steroid use and reduce radiculopathy post-MD.